RVNC

Revance Therapeutics, Inc.
RVNC

Overview Fund Activity
Delisted

RVNC was delisted on the 5th of February, 2025.

Back to rankings

182 hedge funds and large institutions have $1.7B invested in Revance Therapeutics, Inc. in 2022 Q3 according to their latest regulatory filings, with 45 funds opening new positions, 67 increasing their positions, 40 reducing their positions, and 22 closing their positions.

Holders
182
Holders Change
+21
Holders Change %
+13.04%
% of All Funds
3.15%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.07%
New
45
Increased
67
Reduced
40
Closed
22
Calls
$239M
Puts
$90.9M
Net Calls
+$148M
Net Calls Change
+$147M

Top Buyers

1
Capital World Investors
1
Capital World Investors
California
$217M
2
Holocene Advisors
2
Holocene Advisors
New York
$28.8M
3
Jacobs Levy Equity Management
3
Jacobs Levy Equity Management
New Jersey
$24.8M
4
Two Sigma Investments
4
Two Sigma Investments
New York
$30.3M
5
JCAM
5
Jericho Capital Asset Management
New York
$19.3M

Top Sellers

1
HM
1
HealthCor Management
New York
$1.74M
2
JPMorgan Chase & Co
2
JPMorgan Chase & Co
New York
$147M
3
Jennison Associates
3
Jennison Associates
New York
$29M
4
Citadel Advisors
4
Citadel Advisors
Florida
$8.91M
5
HighTower Advisors
5
HighTower Advisors
Illinois
$23.1M
Name Market Value Shares Shares
Change 		Shares
Change %
Capital World Investors
1
Capital World Investors
California
$217M 8,048,838 +3,458,838 +75%
BlackRock
2
BlackRock
New York
$166M 6,131,816 +446,985 +8%
JPMorgan Chase & Co
3
JPMorgan Chase & Co
New York
$147M 5,450,498 -1,237,427 -19%
PAI
4
Palo Alto Investors
California
$119M 4,405,039 – –
Vanguard Group
5
Vanguard Group
Pennsylvania
$116M 4,312,896 +609,841 +16%
Franklin Resources
6
Franklin Resources
California
$64.4M 2,386,018 +19,651 +0.8%
Fidelity Investments
7
Fidelity Investments
Massachusetts
$47.2M 1,748,990 +534,672 +44%
BAMCO Inc
8
BAMCO Inc
New York
$46.5M 1,720,508 +37,500 +2%
State Street
9
State Street
Massachusetts
$43.6M 1,616,453 -163,340 -9%
D.E. Shaw & Co
10
D.E. Shaw & Co
New York
$39.7M 1,469,573 +651,833 +80%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$37.3M 1,383,241 +146,289 +12%
Goldman Sachs
12
Goldman Sachs
New York
$30.8M 1,139,808 +310,883 +38%
Two Sigma Investments
13
Two Sigma Investments
New York
$30.3M 1,121,823 +777,135 +225%
Jennison Associates
14
Jennison Associates
New York
$29M 1,072,235 -683,468 -39%
Holocene Advisors
15
Holocene Advisors
New York
$28.8M 1,065,962 +1,065,962 New
Jacobs Levy Equity Management
16
Jacobs Levy Equity Management
New Jersey
$24.8M 918,275 +854,755 +1,346%
RHJA
17
Rice Hall James & Associates
California
$24.2M 896,754 -188,586 -17%
HighTower Advisors
18
HighTower Advisors
Illinois
$23.1M 855,434 -368,728 -30%
PA
19
Perceptive Advisors
New York
$21.8M 808,671 +236,157 +41%
Northern Trust
20
Northern Trust
Illinois
$19.3M 715,649 +37,349 +6%
JCAM
21
Jericho Capital Asset Management
New York
$19.3M 714,000 +714,000 New
Morgan Stanley
22
Morgan Stanley
New York
$18.4M 682,705 +179,621 +36%
Nuveen Asset Management
23
Nuveen Asset Management
Illinois
$16.7M 619,164 +260,044 +72%
Allspring Global Investments
24
Allspring Global Investments
North Carolina
$15.8M 586,275 +585,888 +151,392%
Assenagon Asset Management
25
Assenagon Asset Management
Luxembourg
$15.5M 575,564 +444,916 +341%
1
2 3 4 5